THEMIS MEDICARE
Back to Income Statement
|
THEMIS MEDICARE Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹406 Cr | ₹382 Cr | ₹354 Cr | ₹395 Cr | ₹231 Cr |
What is the latest Revenue of THEMIS MEDICARE ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹406 Cr |
| Mar2024 | ₹382 Cr |
| Mar2023 | ₹354 Cr |
| Mar2022 | ₹395 Cr |
| Mar2021 | ₹231 Cr |
How is Revenue of THEMIS MEDICARE Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹406 Cr | 6.22 | |
| Mar2024 | ₹382 Cr | 7.74 | |
| Mar2023 | ₹354 Cr | -10.21 | |
| Mar2022 | ₹395 Cr | 71.07 | |
| Mar2021 | ₹231 Cr | - | |
Compare Revenue of peers of THEMIS MEDICARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THEMIS MEDICARE | ₹801.8 Cr | -2.7% | 9.9% | -54.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
THEMIS MEDICARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THEMIS MEDICARE | -2.7% |
9.9% |
-54.1% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses